Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Also... Lim.. anyone..

Also... Lim.. anyone..

posted on Jan 31, 2007 05:56PM

As per posted earlier...

Re: Tcr... Ease...

Posted by BaNosser on January 31, 2007 at 6:58PM
In response to Re: Tcr... Ease... by limerickhook

Lim... from the 2-10-06 PR

http://www.ptsc.com/news/press_relea...


To facilitate the conversion of the debentures, agreements between the Company and Lincoln and Swartz which prohibit each of Lincoln and Swartz from owning more than 4.99% of the Company's Common Stock will be amended to allow them to own up to 9.99% of the Common Stock. With their holdings exceeding 5% they will need to make appropriate SEC filings upon future dispositions of the Company's stock.

I guess I want to know if this is a correct statement or not?

--------

As S&L are selling/converting I want to know why they have not had to file the appropriate forms with the SEC.. S-1s or whatever.... How are they doing this?? Anyone..


--Is this obvious to all, and am I again the only one too obtuse to see the obviousness of it??

Help again...

..and thanks

Share
New Message
Please login to post a reply